Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The British Biosimilars Association (BBA) is the sector group of the British Generic Manufacturers Association (BGMA) dedicated to representing the interests of biosimilar manufacturers in the United Kingdom. The association works closely with the UK government, the NHS, and regulatory bodies like the MHRA to promote the adoption and understanding of biosimilar medicines. By advocating for a sustainable and competitive market, the BBA aims to increase patient access to life-changing biologic treatments while delivering significant cost savings to the healthcare system. Its membership comprises leading global pharmaceutical companies involved in the development, manufacture, and supply of biosimilar products.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on British Biosimilars Association.